IDERA PHARMACEUTICALS, INC.·4

Jun 22, 4:00 PM ET

REARDON WILLIAM S 4

4 · IDERA PHARMACEUTICALS, INC. · Filed Jun 22, 2018

Insider Transaction Report

Form 4
Period: 2018-06-20
Transactions
  • Award

    Stock Options

    2018-06-20$1.53/sh+50,000$76,50050,000 total
    Exercise: $1.53From: 2019-06-20Exp: 2028-06-20Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]These options were granted pursuant to the Company's director compensation on the date of the Company's 2018 annual meeting of stockholders at an exercise price to the closing price of the Company's common stock on the date of grant.
  • [F2]These options will vest in full and become immediately exercisable on the first anniversary of the date of grant, subject to continued service as director, and are granted under the Company's 2013 Stock Incentive Plan, as amended.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -